Retrophin

Pharmaceuticals & Biotech

Retrophin Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Retrophin?

Martin Shkreli (/'skr?li/, born 1983) is an American entrepreneur and pharmaceutical executive. He is co-founder of the hedge fund MSMB Capital Management, co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin, and founder and former CEO of Turing Pharmaceuticals. In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56 (from US$13.5 to US$750 per pill), leading him to be referred to by media as the "most hated man in America". In December 2015, Shkreli was arrested by the FBI after being indicted on federal charges of securities fraud. He is free on bail pending trial. He resigned as CEO of Turing Pharmaceuticals and was replaced by the companys board chairman, Ron Tilles. Shkreli was born in Coney Island Hospital, Brooklyn. He is the son of Albanian and Croatian immigrants who worked as janitors. He, his two sisters, and his brother grew up in a working class community in Sheepshead Bay, Brooklyn. Shkreli was raised Catholic, and attended Sunday school as a child.

Highest paying job titles at Retrophin include Clinical Data Manager, Communications Director, and Director of Regulatory Affairs

Snapshot

Employees214
Market Cap$678.8 million
Revenue$165.1 million
5 Year Trend+26.8%
Net Income-$103 million
NASDAQRTRX
Founded2011
Annual Report
Total value of jobs:
$5,785,000
Total Jobs:
18
Average Pay:
$148,333
Total Experts:
1
% Masters:
50%

Top Experts at Retrophin

Retrophin Salaries

Clinical Data Manager

$90K

$90K

Average Salary:$90,000

Communications Director

$125K

$125K

Average Salary:$125,000

Director of Regulatory Affairs

$225K

$225K

Average Salary:$225,000

Clinical Director

$225K

$225K

Average Salary:$225,000

View All Salaries